The moment that defined Justin Fulcher‘s career didn’t happen in a boardroom or a university lecture hall. It happened on a street in Jakarta, where he watched a man drink contaminated water from the ground while holding an Android smartphone. The image crystallized something Fulcher had been observing across Southeast Asia: consumer technology had arrived in places where basic infrastructure had not. Healthcare, like clean water, was nowhere to be found.

Fulcher was already an unconventional figure by then. He had taught himself to code at seven, launched a business at thirteen, and left Clemson University behind because it wasn’t moving fast enough. A three-month trip to Southeast Asia had stretched into years. The Jakarta scene gave those years a purpose.

Building RingMD From the Ground Up

He started writing code for a prototype without a name or a pitch deck. Within months, investors came to him. That prototype became RingMD, incorporated in Singapore and built to connect patients with doctors across a region where the need was acute.

The platform Fulcher built was more than a video call service. Patients could input symptoms, filter providers by location, price, and insurance coverage, upload files mid-consultation, and transmit vital signs from wearable devices in real time. Doctors had access to EMR history in a split-screen view and could share notes in both text and video formats. Artificial intelligence modules offered clinical decision support alongside population-level health insights drawn from anonymized data.

Scale, Recognition, and a Hard-Won User Base

At its peak, RingMD held 1.5 million patient records across more than fifty countries, with 10,000 healthcare providers on the platform. In 2017, Microsoft named Fulcher a “Data Culture Champion in Asia” and Forbes placed him on its 30 Under 30 Asia list. Among the platform’s most significant partnerships was a collaboration with the Indian government under the Digital India programme, extending telehealth services to rural communities with limited access to in-person care.

Getting doctors to trust the platform had been as demanding as building it. Justin Fulcher framed his pitch to skeptical practitioners carefully: telehealth was not a replacement for clinic visits but an addition to them. That argument, repeated across markets, eventually took hold. Today, Justin Fulcher pursues a doctorate at Johns Hopkins SAIS and works as a defense technology investor, though his answer when asked what drives him still points forward: “I’ve become less interested in celebrating outcomes and more interested in studying what endures.” Refer to this article for more information.

 

Follow for more information about Justin Fulcher on https://www.facebook.com/JustinLFulcher/